For example, IDO mediates relevant cancers such as breast cancer and ovarian plasma adenocarcinoma through the Trp-AhR pathway, while in the testis, it mediates testicular immune privilege, preventing the body’s immune cells from attacking their own antigens. This evidence concerns the gene AHR and cancer.